Explore more publications!

The LATAM Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Ledger.

Press releases published on January 23, 2026

Larry Rubin Campaign Files First FEC Report, Becomes Fastest-Growing Campaign in TX-38
Navegando la Próxima Ola: La Evolución del Infoentretenimiento Marino y SmartMyBoat Navigator
Brazilian machinery industry expands IPPE presence by 30%, reaching record participation in 2026
La industria brasileña de maquinaria y equipos textiles estará presente en Colombiatex 2026
Domestic Metals Engages ICP Securities Inc. for Automated Market Making Services and provides further details on the engagement of Michael Pound
Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M
XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Elcora Closes First Tranche of Private Placement
AIM ImmunoTech Announces Key Dates and Terms Related to Announced Rights Offering
FENIX360 Secures USD 90 Million Equity Commitment from GEM Global Yield
Azalea Med Spa: A Sanctuary for Regeneration & Well-Being
BioCryst Completes Acquisition of Astria Therapeutics, Expanding Leadership in Hereditary Angioedema 
Skyharbour Invites Shareholders to Upcoming Conferences
Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq
Equinox Gold Completes Sale of Brazil Operations for Total Cash Consideration of US$1.015 Billion; Pays Down More than US$800 Million of Debt With Net Debt Reduced to US$150 Million
Copperhead Confirms Effective Date for Name and Stock Symbol Change
Stallion Uranium Commences Ground Gravity Survey on Additional High Priority Drill Targets
WestKam Gold Corp. Announces up to $300,000 Non-Brokered Private Placement
FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions